SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS is experiencing significant volatility driven by intense debate over whether the recent share price decline is a coordinated manipulation to force retail capitulation before final REGAL clinical trial results, or a justified adjustment due to trial delays and valuation concerns. The community remains deeply divided, with long-term shareholders continuing to emphasize the efficacy of GPS in AML and the potential for a buyout, while others express frustration over management's silence during this quiet period.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is trending following reports that Anthropic is the mystery customer behind the company's $13.7 billion six-year compute deal. While the community is debating the impact of the Anthropic partnership and the potential for a short squeeze given high short interest, some traders are expressing caution regarding dilution risks and execution hurdles for the Georgia data center project.

The Elmet Group Co. engages in the provision of precision-engineered components. The firm offers its products and solutions to aerospace, defense, industrial, medical, semiconductor, electronics, energy industry and also the government. It operates through the Critical Materials Components and Engineered Microwave Products business divisions. The company was founded on September 13, 2024 and is headquartered in Portland, ME.

Elmet Group Co. (The)

The Elmet Group

ELMT is trending following a government-backed $450 million investment and a potential $2 billion defense contract, though the stock has faced volatility amid community debate over whether financing terms constitute a dilutive offering. While bulls emphasize the company's strategic position in the domestic tungsten supply chain, skeptics are expressing concern about the potential for future share issuance.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Semiconductor stocks are trending due to a sharp sell-off sparked by debates over the pace of AI development and calls for stricter industry oversight. While some traders are capitalizing on the volatility, there is significant disagreement regarding whether the decline represents a fundamental shift in AI infrastructure demand or a temporary, sentiment-driven correction.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as traders weigh the company's aggressive AI infrastructure investments against a broader tech sector selloff, though retail sentiment remains heavily bolstered by news that Chairman Larry Ellison canceled his multibillion-dollar stock sale plan.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is receiving attention following the release of positive topline results from its Phase 3 Panorama study of DT120, a lysergide-based tablet for generalized anxiety disorder. Traders are actively discussing the study's success in meeting primary and secondary endpoints, the potential for an upcoming NDA filing, and speculation regarding a possible acquisition.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are trending as traders react to a potential industry-wide slowdown in AI model development, with many viewing the pullback as an opportunity to buy the dip given the continued robust demand for AI infrastructure. Debate persists over whether the call for safety guardrails represents a true operational shift or merely tactical positioning, while investors remain focused on strong long-term revenue projections and compute infrastructure needs.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

The Breakwave Tanker Shipping ETF is surging as traders speculate on the impact of ongoing geopolitical tensions and supply disruptions in the Strait of Hormuz on global tanker freight rates. Discussion is dominated by the volatility of freight futures, with many users debating the sustainability of the rally and the potential for a sharp reversal should regional conditions stabilize.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are under pressure as traders weigh concerns over the pace of AI development against rising oil prices and climbing Treasury yields ahead of the upcoming Federal Reserve policy meeting. While sentiment is extremely bearish among many participants, some investors view the volatility as a potential buying opportunity, citing strong underlying infrastructure demand.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is trending as investors react to a significant selloff following weak third-quarter bookings guidance, with the community split between those viewing the decline as a major buying opportunity and others highlighting concerns over monetization, regulatory risks, and child safety. Traders are closely monitoring key support levels and potential short-covering momentum after the stock's sharp price decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jupiter Neurosciences Lands Potential $100 Million Psychedelic Drug Deal as PharmAla Licenses ALA-002

Momentum continues to build across the emerging psychedelic medicine sector as PharmAla Biotech (OTCQB:MDXXF) announced a definitive licensing agreement granting Jupiter Neurosciences (NASDAQ:JUNS) exclusive rights to develop, manufacture, and commercialize ALA-002 in the United States. The agreement, valued at up to approximately US$100 million in potential consideration, reflects the growing interest in next-generation neuropsychiatric therapies and strategic partnerships designed to advance promising clinical assets while managing development risk.

Micro-Cap Biotech Stocks Surge After Breakthrough Psychedelics Licensing Announcement

The psychedelics market continues to expand rapidly as researchers gain a deeper understanding of its potential therapeutic benefits. Today, a leader in the sector announced a partnership with another micro-cap biotech company to further advance its development efforts in the space. Investors responded positively to the news, sending shares of both companies sharply higher following the announcement.PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) announced that it has signed a term sheet with Jupiter Neurosciences, Inc. (NASDAQ: JUNS) to grant the company exclusive perpetual U.S. ...

PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.

PharmAla Biotech Holdings Inc.

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Current Price	$0.2398
Prev Close	$0.2228
Open	$0.2399
Dividend Yield	0.00%
50-Day Moving Average	$0.135
Beta	0.00
Avg. Volume	23,866.43
PE Ratio	-20.63

52-Week High	$0.24
52-Week Low	$0.0614
Market Capitalization	$24.34M
EPS (Annual)	-$0.0156
Price to Book	17.37
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

MDXXF Fundamentals